PubMed

Rationally designed tularemia vaccines.

Mann BJ, Ark NM.

Expert Rev Vaccines. 2009 Jul;8(7):877-85. Review.PMID: 19538114 [PubMed - indexed for MEDLINE]Related articles

Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis.

Kirimanjeswara GS, Olmos S, Bakshi CS, Metzger DW.

Immunol Rev. 2008 Oct;225:244-55. Review.PMID: 18837786 [PubMed - indexed for MEDLINE]Related articles

Cytokine response in Balb/c mice infected with Francisella tularensis LVS and the Pohang isolate.

Kim EJ, Park SH, Choi YS, Shim SK, Park MY, Park MS, Hwang KJ.

J Vet Sci. 2008 Sep;9(3):309-15.PMID: 18716452 [PubMed - indexed for MEDLINE]Related articlesFree article

Transcriptional profiling of Francisella tularensis infected peripheral blood mononuclear cells: a predictive tool for tularemia.

Paranavitana C, Pittman PR, Velauthapillai M, Zelazowska E, Dasilva L.

FEMS Immunol Med Microbiol. 2008 Oct;54(1):92-103. Epub 2008 Aug 1.PMID: 18680519 [PubMed - indexed for MEDLINE]Related articles

Francisella tularensis: unravelling the secrets of an intracellular pathogen.

Oyston PC.

J Med Microbiol. 2008 Aug;57(Pt 8):921-30. Review.PMID: 18628490 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhalation of Francisella novicida Delta mglA causes replicative infection that elicits innate and adaptive responses but is not protective against invasive pneumonic tularemia.

West TE, Pelletier MR, Majure MC, Lembo A, Hajjar AM, Skerrett SJ.

Microbes Infect. 2008 Jun;10(7):773-80. Epub 2008 Apr 22.PMID: 18539500 [PubMed - indexed for MEDLINE]Related articlesFree article

A conserved and immunodominant lipoprotein of Francisella tularensis is proinflammatory but not essential for virulence.

Forestal CA, Gil H, Monfett M, Noah CE, Platz GJ, Thanassi DG, Benach JL, Furie MB.

Microb Pathog. 2008 Jun;44(6):512-23. Epub 2008 Jan 17.PMID: 18304778 [PubMed - indexed for MEDLINE]Related articlesFree article

Tularemia vaccines - an overview.

McMurry JA, Moise L, Gregory SH, De Groot AS.

Med Health R I. 2007 Oct;90(10):311-4. Review.PMID: 18019188 [PubMed - indexed for MEDLINE]Related articles

Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.

Li J, Ryder C, Mandal M, Ahmed F, Azadi P, Snyder DS, Pechous RD, Zahrt T, Inzana TJ.

Microbiology. 2007 Sep;153(Pt 9):3141-53.PMID: 17768257 [PubMed - indexed for MEDLINE]Related articlesFree article

Generation and characterization of hybridoma antibodies for immunotherapy of tularemia.

Lu Z, Roche MI, Hui JH, Unal B, Felgner PL, Gulati S, Madico G, Sharon J.

Immunol Lett. 2007 Oct 15;112(2):92-103. Epub 2007 Aug 8.PMID: 17764754 [PubMed - indexed for MEDLINE]Related articlesFree article

From rabbits to humans: the contributions of Dr. Theodore E. Woodward to tularemia research.

Cross AS, Calia FM, Edelman R.

Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S61-7.PMID: 17582573 [PubMed - indexed for MEDLINE]Related articles

Biosafety and selectable markers.

Titball RW, Sjostedt A, Pavelka MS Jr, Nano FE.

Ann N Y Acad Sci. 2007 Jun;1105:405-17. Epub 2007 Apr 7. Review.PMID: 17416926 [PubMed - indexed for MEDLINE]Related articles

Animal models of Francisella tularensis infection.

Rick Lyons C, Wu TH.

Ann N Y Acad Sci. 2007 Jun;1105:238-65. Epub 2007 Mar 29. Review.PMID: 17395735 [PubMed - indexed for MEDLINE]Related articles

Vaccines against Francisella tularensis.

Wayne Conlan J, Oyston PC.

Ann N Y Acad Sci. 2007 Jun;1105:325-50. Epub 2007 Mar 29. Review.PMID: 17395730 [PubMed - indexed for MEDLINE]Related articles

Mucosal immunopathogenesis of Francisella tularensis.

Metzger DW, Bakshi CS, Kirimanjeswara G.

Ann N Y Acad Sci. 2007 Jun;1105:266-83. Epub 2007 Mar 29. Review.PMID: 17395728 [PubMed - indexed for MEDLINE]Related articles

Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations.

Sjöstedt A.

Ann N Y Acad Sci. 2007 Jun;1105:1-29. Epub 2007 Mar 29. Review.PMID: 17395726 [PubMed - indexed for MEDLINE]Related articles

Transcriptome analysis of human immune responses following live vaccine strain (LVS) Francisella tularensis vaccination.

Fuller CL, Brittingham KC, Porter MW, Hepburn MJ, Petitt PL, Pittman PR, Bavari S.

Mol Immunol. 2007 May;44(12):3173-84. Epub 2007 Mar 8.PMID: 17349694 [PubMed - indexed for MEDLINE]Related articlesFree article

Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.

KuoLee R, Harris G, Conlan JW, Chen W.

Vaccine. 2007 May 10;25(19):3781-91. Epub 2007 Feb 26.PMID: 17346863 [PubMed - indexed for MEDLINE]Related articlesFree article

An in vitro model system used to study adherence and invasion of Francisella tularensis live vaccine strain in nonphagocytic cells.

Lindemann SR, McLendon MK, Apicella MA, Jones BD.

Infect Immun. 2007 Jun;75(6):3178-82. Epub 2007 Mar 5.PMID: 17339345 [PubMed - indexed for MEDLINE]Related articlesFree article

Francisella tularensis vaccines.

Griffin KF, Oyston PC, Titball RW.

FEMS Immunol Med Microbiol. 2007 Apr;49(3):315-23. Epub 2007 Feb 22. Review.PMID: 17316369 [PubMed - indexed for MEDLINE]Related articles